| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.08▼ | 2.06▲ | 2.05▲ | 1.96▲ | 1.76▲ |
| MA10 | 2.05▲ | 1.99▲ | 2.00▲ | 1.90▲ | 1.83▲ |
| MA20 | 1.97▲ | 1.94▲ | 1.93▲ | 1.78▲ | 1.94▲ |
| MA50 | 1.92▲ | 1.87▲ | 1.81▲ | 1.86▲ | 1.87▲ |
| MA100 | 1.82▲ | 1.79▲ | 1.79▲ | 1.97▲ | 2.29▼ |
| MA200 | 1.79▲ | 1.89▲ | 1.98▲ | 1.87▲ | 2.15▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.011▲ | 0.015▲ | 0.016▲ | 0.043▲ | -0.013▼ |
| RSI | 59.256▲ | 59.229▲ | 59.043▲ | 56.927▲ | 52.645▲ |
| STOCH | 85.900▲ | 91.895▲ | 90.074▲ | 68.569 | 34.877 |
| WILL %R | -16.129▲ | -16.129▲ | -13.889▲ | -18.571▲ | -61.828 |
| CCI | 69.220 | 114.799▲ | 111.320▲ | 153.327▲ | 0.038 |
|
Thursday, November 13, 2025 04:00 AM
SAN DIEGO and SUZHOU, China and SPRING HOUSE, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG) and Third Arc Bio, Inc. (“Third Arc Bio”), today announced a licensing ...
|
|
Wednesday, November 12, 2025 04:00 PM
An update from Adagene ( (ADAG)) is now available. On November 13, 2025, Adagene Inc. announced a licensing agreement with Third Arc Bio, allowing the latter to use Adagene’s SAFEbody technology to ...
|
|
Friday, October 31, 2025 12:00 AM
Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based on previous alignment with FDA Patients randomized to either 10 or 20 mg/kg of muzastotug, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/11/25 | 2.14 | 2.14 | 2.00 | 2.01 | 38,793 |
| 26/11/25 | 2.02 | 2.14 | 1.90 | 2.12 | 173,766 |
| 25/11/25 | 1.97 | 2.05 | 1.78 | 1.99 | 255,752 |
| 24/11/25 | 2.00 | 2.00 | 1.80 | 1.90 | 81,179 |
| 21/11/25 | 1.74 | 1.873 | 1.74 | 1.80 | 3,291,581 |
| 20/11/25 | 1.82 | 1.88 | 1.74 | 1.77 | 79,098 |
| 19/11/25 | 1.918 | 1.98 | 1.80 | 1.81 | 36,821 |
| 18/11/25 | 1.82 | 1.99 | 1.802 | 1.9834 | 49,659 |
| 17/11/25 | 1.86 | 1.90 | 1.78 | 1.82 | 22,756 |
| 14/11/25 | 1.88 | 1.90 | 1.80 | 1.83 | 31,113 |
|
|
||||
|
|
||||
|
|